The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Opportunistic Infections in Patients with and Patients without Acquired Immunodeficiency Syndrome
Abstract
In the next decade, longer survival of patients with cancer and more-aggressive therapies applied to common conditions, such as asthma and rheumatoid arthritis, will result in a larger population with significant immune system defects. Many in this population will be at risk for opportunistic infections, which are familiar to doctors who have treated people infected with human immunodeficiency virus (HIV). However, the epidemiology, presentation, and outcome of these infections in patients with an immune system defect, other than that caused by HIV infection, may be different than those encountered in patients with acquired immunodeficiency syndrome. Reviewed are 4 common opportunistic infections: Pneumocystis carinii pneumonia, cryptococcosis, atypical mycobacterial infection, and cytomegalovirus infection. Emphasized are the important differences among these groups at risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Practice Guidelines for the Management of Cryptococcal Disease
Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D., Dismukes, W. E., & Mycoses Study Group Cryptococcal Subproject (2000) · Clinical Infectious Diseases · doi:10.1086/313757 · Cited by 1,105
KOVACS, J. A., HIEMENZ, J. W., MACHER, A. M., STOVER, D., MURRAY, H. W., SHELHAMER, J., LANE, H. C., URMACHER, C., HONIG, C., LONGO, D. L., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-663 · Cited by 855
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 820
Kaplan, J. E., Hanson, D., Dworkin, M. S., Frederick, T., Bertolli, J., Lindegren, M. L., Holmberg, S., & Jones, J. L. (2000) · Clinical Infectious Diseases · doi:10.1086/313843 · Cited by 705
Infection with Mycobacterium avium Complex in Patients without Predisposing Conditions
Prince, D. S., Peterson, D. D., Steiner, R. M., Gottlieb, J. E., Scott, R., Israel, H. L., Figueroa, W. G., & Fish, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211304 · Cited by 688
Yale, S. H., & Limper, A. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.5 · Cited by 644
Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' Experience
Meyers, J. D., Flournoy, N., & Thomas, E. D. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.6.1119 · Cited by 522
Limper, A. H., Offord, K. P., Smith, T. F., & Martin, W. J. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.5.1204 · Cited by 494
WALZER, P. D., PERL, D. P., KROGSTAD, D. J., RAWSON, P. G., & SCHULTZ, M. G. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-1-83 · Cited by 466
Cited by
Thomas, C. F., & Limper, A. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032588 · Cited by 1,037
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 669
Limper, A. H., Knox, K. S., Sarosi, G. A., Ampel, N. M., Bennett, J. E., Catanzaro, A., Davies, S. F., Dismukes, W. E., Hage, C. A., Marr, K. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2008-740st · Cited by 612
on behalf of the Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group, Kroschinsky, F., Stölzel, F., von Bonin, S., Beutel, G., Kochanek, M., Kiehl, M., & Schellongowski, P. (2017) · Critical Care · doi:10.1186/s13054-017-1678-1 · Cited by 500
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Stern, A., Green, H., Paul, M., Vidal, L., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005590.pub3 · Cited by 452
Green, H., Paul, M., Vidal, L., & Leibovici, L. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1052 · Cited by 379
Diagnosis of severe respiratory infections in immunocompromised patients
Azoulay, E., Russell, L., Van de Louw, A., Metaxa, V., Bauer, P., Povoa, P., Montero, J. G., Loeches, I. M., Mehta, S., Puxty, K., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05906-5 · Cited by 346
Current insights into the biology and pathogenesis of Pneumocystis pneumonia
Thomas, C. F., & Limper, A. H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1621 · Cited by 275
Pneumocystis jirovecii pneumonia in kidney transplantation
Goto, N., & Oka, S. (2011) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00691.x · Cited by 74
Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment
Krajicek, B. J., Thomas, C. F., & Limper, A. H. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.005 · Cited by 73
Fungal Infections in Transplant and Oncology Patients
Person, A. K., Kontoyiannis, D. P., & Alexander, B. D. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.11.013 · Cited by 33
Metadata
- Authors
- Sepkowitz, K. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04-15
- Volume
- 34
- Issue
- 8
- Pages
- 1098-1107
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2124791110
- Cited by
- 501
- References
- 54
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.